AAV NRF2 Gene Therapy Preserves Retinal Structure and Function in Rodent Models of Oxidative Damage
Apolonia GardneriD, Shuai WangiD, Adam Daniels, Dan Dan LiiD, Christine C. WuiD, Lucas LiniD, Christin M. HongiD, Sophia R. ZhaoiD, Richard T. BorniD, Kamil Kruczek, Genevieve Weist, Laura Barrio Real, Joan Wicks, Mohamad Nayal, Ashley Carter, Christine Ott, Virginia HaurigotiD, Constance L. CepkoiD
Abstract
Dry age-related macular degeneration is the most frequent cause of visual impairment in individuals over age 50 in developed countries. It is characterized by subretinal deposits of oxidized proteins and lipids and results in progressive loss of high acuity vision. One major risk factor is smoking, which causes oxidative stress in many tissues, including the eye. We previously showed that an adeno-associated viral vector expressing human NRF2 (AAV8/Best1-Nrf2), a transcription factor that regulates responses to oxidative damage, slowed degeneration in mouse models of another blinding disorder, retinitis pigmentosa, which also includes oxidative stress. Here, our AAV8/Best1-Nrf2 vector was tested in a model of oxidative stress wherein sodium iodate was injected systemically, as this is often used to model dry age-related macular degeneration. Sodium iodate causes acute oxidative damage to supporting cells of the retina, the retinal pigment epithelial cells, and ultimately leads to photoreceptor death. Subretinal injection of AAV8/Best1-Nrf2 led to protection of the retinal pigment epithelium and photoreceptors, as well as preservation of visual function, in rat and mouse sodium iodate models. AAV8/Best1-Nrf2 may serve as an effective gene-agnostic therapy for diseases with oxidative stress, including dry age-related macular degeneration. ETOCOxidative stress occurs in diseases that lead to vision loss, including age-related macular degeneration (AMD). AMD is commonly modeled by injection of sodium iodate (S.I.), an oxidizing agent. AAV-mediated delivery of Nrf2, a transcription factor that regulates oxidative stress, protects the eye from S.I. damage in rat and mouse models. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=198 SRC="FIGDIR/small/663952v1_ufig1.gif" ALT="Figure 1"> View larger version (67K): org.highwire.dtl.DTLVardef@357e57org.highwire.dtl.DTLVardef@1f9986dorg.highwire.dtl.DTLVardef@186537corg.highwire.dtl.DTLVardef@1d31aad_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 7
- FWCI
- 14.36
- Field percentile
- top 1%
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- AAV-NRF2 protects retinal and choroidal vasculature in a GDF15-dependent manner in an oxidative damage model of AMD
Shuai Wang, Sophia Zhao, … Constance L. Cepko·Proceedings of the National Academy of SciencesPeer-reviewed·Aug 11, 2026
- Functional and molecular profiles of the neuroretina and retinal pigmented epithelium-choroid in response to aging and Nrf2 deletion
Becca L. Wells, Adrian Filiberti, … Ana J. Chucair‐Elliott·bioRxiv·Oct 9, 2026
- Modulation of Retinal Inflammation Delays Degeneration in a Mouse Model of Geographic Atrophy
Raela B Ridley, Brianna M Tischner, … Cristhian J. Ildefonso·Scientific ReportsPeer-reviewed·Aug 17, 2025
- Age-related macular degeneration-like phenotypic features develop at the early ages of Cxcr5/Nrf2 double knockout mice: An accelerated AMD model
H. Huang, A. Lennikov·bioRxiv·Dec 8, 2019
- Systemic Treatment with Nicotinamide Riboside is Protective in Three Mouse Models of Retinal Degeneration
Xian Zhang, Nathaniel F. Henneman, … Jeffrey H. Boatright·Investigative Ophthalmology & Visual SciencePeer-reviewed·Aug 27, 2020
- A2E induces the transactivation of RARs, PPARs and RXRs and its effects are counteracted by norbixin in retinal pigment epithelium cells in vitro
V. Fontaine, M. Fournie, … S. Camelo·bioRxiv·Mar 30, 2020